Healthy high growth potential
Results
2
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
2 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
BIOPOR | DKK 1.07 | -5.8% | -23.9% | DKK 527.3m | DKK 1.75 | 13.1 | 78.5% | n/a | Pharmaceuticals & Biotech | ||
CBRAIN | DKK 48.40 | -3.0% | -76.1% | DKK 946.6m | DKK 105.00 | 22.0 | 31.9% | 2.1% | Software |
Page 1 of 1
